Nivolumab is used for the treatment of patients with skin cancer, (melanoma), non-small cell lung cancer, kidney cancer...

Nivolumab is a cancer medicine that is used alone or in combination with other medicines to treat advanced skin cancer, (melanoma), non-small cell lung cancer, kidney cancer, classical Hodgkin lymphoma, squamous cell cancer of the head and neck, bladder cancer, liver cancer or a type of colorectal cancer that laboratory testing proves to have certain specific DNA mutations.

Nivolumab suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Nivolumab brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Nivolumab tablets cost price in India.

The order for Nivolumab will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Injection: 40 mg/4 mL, 100 mg/10 mL, and 240 mg/24 mL solution in a single-dose vial.


Nivolumab tablets, for oral use is available.

Get In Touch

Nivolumab suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Nivolumab on prescription and Import License in Patient's Name only.

For overseas patients, Nivolumab can be made available in Send your enquiry to find Nivolumab in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for Alunbrig (Nivolumab).

ASH 2019: Brentuximab Vedotin in Combination with Nivolumab in Frontline and R/R Hodgkin Lymphoma For More Details

Nivolumab/Ipilimumab Shows More Promising Results in Patients with Melanoma For More Details

Channel Partner In India


  • Address:60/4, T&T House. Yusuf Sarai, New Delhi:110016
  • Phone +91-11-26532129
  • Email: IPN, New Delhi


  • Address: #308, Raheja Chambers, 12, Museum Road, Bangalore 560 001
  • Email: IPN, Bangalore


  • Address: 1/A R.G Kar Road, Shayambazar, Kolkata 700004
  • Email: IPN, Kolkata


  • Address: 203-A, 2nd Floor, Tower -11, Felix Square, IBB-2, Sushant Golf city, Lucknow 226030
  • Email: IPN, Lucknow